Trial · NCT07884474
Feasibility and Acceptability of Remote Saliva Collection
NCT07884474, Recruiting, St. Jude Children's Research Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Feasibility and Acceptability of Remote Saliva Collection. Trials, record NCT07884474. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07884474
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Feasibility and Acceptability of Remote Saliva Collection
- NCT number
- NCT07884474
- Status
- Recruiting
- Enrollment
- 100 participants, estimated
- Lead sponsor
- St. Jude Children's Research Hospital
- Conditions
- Survivors of Childhood Cancer, Acute Lymphoblastic Leukemia, Childhood
- Interventions
Salivary Cortisol Collection, Blood Biomarker Collection, Hair Cortisol Collection, Nail Cortisol Collection, WatchPAT Sleep Assessment, Morning and Evening Diaries, MEMS Cap Adherence Monitoring, OnTimePoint Application, Survey and Questionnaire Assessment
- First posted
- 2026-10-20
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes26
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Enrollment Feasibility | Baseline through study completion, approximately 3 months after enrollment | Proportion of participants approached that enroll in the study |
| Primary | Saliva Sampling Feasibility | Baseline through study completion, approximately 3 months after enrollment | Proportion of participants who complete the saliva sampling procedures will adhere to the timing of the saliva sampling |
| Primary | Blood Sampling Feasibility | Baseline through study completion, approximately 3 months after enrollment | Proportion of participants enrolled who complete the blood sample collection |
| Primary | Hair Sampling Feasibility | Baseline through study completion, approximately 3 months after enrollment | Proportion of participants enrolled that completed the hair sample collection |
| Primary | Fingernail Sampling Feasibility | Baseline through study completion, approximately 3 months after enrollment | Proportion of participants enrolled that completed the fingernail sample collection |
| Primary | Overall Study Procedure Feasibility | Baseline through study completion, approximately 3 months after enrollment | Proportion of participants enrolled that completed each study procedure |
| Secondary | Saliva Sampling Acceptability-Acceptability Measure | Post study, approximately 3 months after enrollment | A measure of saliva sampling acceptability. Scores of ≥4 on a 5-point Likert scale will be indicative of intervention acceptability. |
| Secondary | Blood Sampling Acceptability-Acceptability Measure | Post study, approximately 3 months after enrollment | A measure of blood sampling acceptability. Scores of ≥4 on a 5-point Likert scale will be indicative of intervention acceptability. |
| Secondary | Hair Sampling Acceptability-Acceptability Measure | Post study, approximately 3 months after enrollment | A measure of hair sampling acceptability. Scores of ≥4 on a 5-point Likert scale will be indicative of intervention acceptability. |
| Secondary | Fingernail Sampling Acceptability-Acceptability Measure | Post study, approximately 3 months after enrollment | A measure of fingernail sampling acceptability. Scores of ≥4 on a 5-point Likert scale will be indicative of intervention acceptability. |
1 to 10 of 26Source ClinicalTrials.gov
See all 26 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| U54CA302464 | Reducing Disparities in Acute Leukemia (REDIAL) Consortium | GRAMATGES, MARIA MONICA; LUPO, PHILIP; RABIN, KAREN R | BAYLOR COLLEGE OF MEDICINE | NATIONAL CANCER INSTITUTE | 2025 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07884474
GET https://conductscience.org/api/trials/v1/NCT07884474/registered?page=2